John Öhd

1.1k citations

30 papers · 883 indexed · h-index 16

Impact in

Pharmacology top 5%
- Inflammatory mediators and NSAID effects
Cancer Research top 10%

Papers in ⓘ

Molecular Biology 12
- Bone Metabolism and Diseases 3
Pharmacology 10
- Inflammatory mediators and NSAID effects 9

Co-authors: Anita Sjölander (9 shared papers)Katarina Wikström (6 shared papers)Christian Kamp Nielsen (3 shared papers)Joan Campbell-Tofte (2 shared papers)Göran Landberg (2 shared papers)Helge Löfberg (1 shared paper)Jonas Bergh (5 shared papers)Kristian Riesbeck (1 shared paper)
Journals: Blood (2 papers)Advances in experimental medicine and biology (2 papers)European Journal of Cancer (2 papers)Annals of Oncology (2 papers)Osteoarthritis and Cartilage (2 papers)
Partner nations: Sweden United States United Kingdom

In The Last Decade

John Öhd

30 papers receiving 874 citations

Peers

Countries citing papers authored by John Öhd

Since Specialization

Citations

This map shows the geographic impact of John Öhd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Öhd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Öhd more than expected).

Fields of papers citing papers by John Öhd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Öhd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Öhd. The network helps show where John Öhd may publish in the future.

Co-authors

The 25 scholars most cited alongside John Öhd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Öhd Line = papers co-authored together John Öhd links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas Gastroenterology ·John Öhd, Christian Kamp Nielsen, Joan Campbell-Tofte, Göran Landberg, Helge Löfberg, Anita Sjölander	2003	156
2	Disease-Modifying Effects of a Novel Cathepsin K Inhibitor in Osteoarthritis Annals of Internal Medicine ·Philip G. Conaghan, M.A. Bowes, Sarah R. Kingsbury, Alan Brett, Gwenael Guillard, Biljana Rizoska, Niclas Sjögren, Philippa Graham, Åsa Jansson, Cecilia Wadell, Richard C. Bethell, John Öhd	2019	108
3	Leukotrienes induce cell-survival signaling in intestinal epithelial cells Gastroenterology ·John Öhd, Katarina Wikström, Anita Sjölander	2000	95
4	A Novel Localization of the G-Protein-Coupled CysLT1 Receptor in the Nucleus of Colorectal Adenocarcinoma Cells Cancer Research ·Christian Kamp Nielsen, Joan Campbell-Tofte, John Öhd, Matthias Mörgelin, Kristian Riesbeck, Göran Landberg, Anita Sjölander	2005	95
5	Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study BMC Medicine ·Per Hall, Alexander Ploner, Judith Bjöhle, Fei Huang, Chin‐Yo Lin, Edison T. Liu, Lance D. Miller, Hans Nordgren, Yudi Pawitan, Peter Shaw, Lambert Skoog, Johanna Smeds, Sara Wedrén, John Öhd, Jonas Bergh	2006	51
6	The Inflammatory Mediator Leukotriene D4 Induces β-Catenin Signaling and Its Association with Antiapoptotic Bcl-2 in Intestinal Epithelial Cells Journal of Biological Chemistry ·Maryna Mezhybovska, Katarina Wikström, John Öhd, Anita Sjölander	2006	50
7	Worse survival for TP53 (p53)-mutated breast cancer patients receiving adjuvant CMF Annals of Oncology ·J. Andersson, Lena Larsson, Sigrid Klaar, Lars Holmberg, Johan Nilsson, Mats Inganäs, Göran Carlsson, John Öhd, C.-M. Rudenstam, Bengt Gustavsson, Jonas Bergh	2005	46
8	Activated ERK1/2 and phosphorylated oestrogen receptor α are associated with improved breast cancer survival in women treated with tamoxifen European Journal of Cancer ·Jenny Bergqvist, Göran Elmberger, John Öhd, Barbro Linderholm, Judith Bjöhle, Henrik Hellborg, Hans Nordgren, Anna-Lena Borg, Lambert Skoog, Jonas Bergh	2006	43
9	Quantitative real-time PCR analysis and microarray-based RNA expression of HER2 in relation to outcome Annals of Oncology ·Jenny Bergqvist, John Öhd, Johanna Smeds, Sigrid Klaar, Jorma Isola, Hans Nordgren, Göran Elmberger, Henrik Hellborg, Judith Bjöhle, Alexander Borg, Lambert Skoog, Jonas Bergh	2007	31
10	The Leukotriene Receptor CYSLT1 And 5- Lipoxygenase Are Upregulated In Colon Cancer Advances in experimental medicine and biology ·Christian Kamp Nielsen, John Öhd, Katarina Wikström, Ramin Massoumi, Sailaja Paruchuri, Maria Juhas, Anita Sjölander	2003	30
11	Regulation of leukotriene-dependent induction of cyclooxygenase-2 and Bcl-2 Biochemical and Biophysical Research Communications ·Katarina Wikström, John Öhd, Anita Sjölander	2003	25
12	A randomized, double-blind, placebo-controlled crossover study of α4β2* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder Psychopharmacology ·Aurelija Jučaitė, John Öhd, Alexandra Potter, Judith Jaeger, Pär Karlsson, Kristín Hannesdóttir, Emma Boström, Paul Newhouse, Björn Paulsson	2013	24
13	Leukotriene D4-Induced Activation and Translocation of the G-Protein αi3-Subunit in Human Epithelial Cells Biochemical and Biophysical Research Communications ·Jonas Adolfsson, John Öhd, Anita Sjölander	1996	24
14	A phase II study of epirubicin, cisplatin and capecitabine as neoadjuvant chemotherapy in locally advanced or inflammatory breast cancer European Journal of Cancer ·Kenneth Villman, John Öhd, Elisabet Lidbrink, Lena Malmberg, Birgitta Lindh, Carl Blomqvist, Hans Nordgren, Jonas Bergh, Daniel Bergström, Johan Ahlgren	2007	18
15	Six months’ treatment with MIV-711, a novel Cathepsin K inhibitor induces osteoarthritis structure modification: results from a randomized double-blind placebo-controlled phase IIA trial Osteoarthritis and Cartilage ·Philip G. Conaghan, M.A. Bowes, Sarah R. Kingsbury, Allan S. Brett, Gwenael Guillard, Karin Tunblad, Biljana Rizoska, Torbjörn Larsson, A Jay Holmgren, Auli Manninen, K. Göhlin, Walter Heber, P. A. Graham, Åsa Jansson, Cecilia Wadell, Richard C. Bethell, John Öhd	2018	15
16	Human papillomavirus, viral load and proliferation rate in recurrent respiratory papillomatosis in response to alpha interferon treatment Journal of General Virology ·Michael Szeps, Liselotte Dahlgren, Leena‐Maija Aaltonen, John Öhd, Lena Kanter-Lewenshon, Hanna Dahlstrand, Eva Munck‐Wikland, Dan Grandér, Tina Dalianis	2005	15
17	Assessment of in vivo mast cell reactivity in patients with systemic mastocytosis Clinical & Experimental Allergy ·Theo Gülen, Christine Möller Westerberg, Katarina Lyberg, Maria Ekoff, Johan Kolmert, Johan Bood, John Öhd, Anna James, Sven‐Erik Dahlén, Gunnar Nilsson, Barbro Dahlén	2017	13
18	Pro-inflammatory mediator leukotriene D4 induces transcriptional activity of potentially oncogenic genes Biochemical Society Transactions ·Maryna Mezhybovska, Katarina Wikström, John Öhd, Anita Sjölander	2005	10
19	A quantitative LC/MS method targeting urinary 1-methyl-4-imidazoleacetic acid for safety monitoring of the global histamine turnover in clinical studies Analytical and Bioanalytical Chemistry ·Johan Kolmert, Benita H. Forngren, Johan Lindberg, John Öhd, K. Magnus Åberg, Gunnar Nilsson, Thomas Möritz, Anders Nordström	2014	7
20	Efficacy and Safety of Sevuparin, a Novel Non-Anti-Coagulant Heparinoid, in Patients with Acute Painful Vaso-Occlusive Crisis; A Global, Multicenter Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial (TVOC01) Blood ·Bart J. Biemond, Anıl Tombak, Yurdanur Kılınç, Murtadha Al‐Khabori, Miguel R. Abboud, Mohammed Nafea, Adlette Inati, Yasser Wali, Jens Kristensen, Ellen Donnelly, John Öhd	2019	6

About John Öhd

John Öhd is a scholar working on Molecular Biology, Pharmacology, Oncology, Genetics and Surgery, having authored 30 papers that have together received 883 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (9 papers), Estrogen and related hormone effects (5 papers), Cytokine Signaling Pathways and Interactions (4 papers), Helicobacter pylori-related gastroenterology studies (4 papers), Asthma and respiratory diseases (3 papers), Bone Metabolism and Diseases (3 papers), Breast Cancer Treatment Studies (2 papers) and Osteoarthritis Treatment and Mechanisms (2 papers). The work is most often cited by research in Pharmacology (223 citations), Cancer Research (175 citations), Oncology (261 citations), Biochemistry (68 citations) and Immunology and Allergy (51 citations). John Öhd has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Anita Sjölander, Katarina Wikström, Christian Kamp Nielsen, Joan Campbell-Tofte, Göran Landberg, Helge Löfberg, Jonas Bergh, Kristian Riesbeck, Matthias Mörgelin and Hans Nordgren. Their work appears in journals such as Blood, Advances in experimental medicine and biology, European Journal of Cancer, Annals of Oncology and Osteoarthritis and Cartilage.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact